KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Cash from Investing Activities: 2010-2025

Historic Cash from Investing Activities for Astrana Health (ASTH) over the last 16 years, with Q3 2025 value amounting to -$534.5 million.

  • Astrana Health's Cash from Investing Activities fell 649271.0% to -$534.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$540.3 million, marking a year-over-year decrease of 13481.64%. This contributed to the annual value of -$192.4 million for FY2024, which is 19362.97% down from last year.
  • Per Astrana Health's latest filing, its Cash from Investing Activities stood at -$534.5 million for Q3 2025, which was down 649271.0% from -$1.1 million recorded in Q2 2025.
  • Astrana Health's 5-year Cash from Investing Activities high stood at $39.1 million for Q4 2021, and its period low was -$534.5 million during Q3 2025.
  • Over the past 5 years, Astrana Health's median Cash from Investing Activities value was -$10.5 million (recorded in 2021), while the average stood at -$41.4 million.
  • In the last 5 years, Astrana Health's Cash from Investing Activities soared by 17338.28% in 2021 and then crashed by 649271.0% in 2025.
  • Astrana Health's Cash from Investing Activities (Quarter) stood at $39.1 million in 2021, then plummeted by 66.22% to $13.2 million in 2022, then tumbled by 186.56% to -$11.4 million in 2023, then crashed by 191.63% to -$33.3 million in 2024, then crashed by 1503.86% to -$534.5 million in 2025.
  • Its Cash from Investing Activities was -$534.5 million in Q3 2025, compared to -$1.1 million in Q2 2025 and -$2.4 million in Q1 2025.